GRANDALIANO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 5.053
NA - Nord America 4.983
AS - Asia 2.014
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
SA - Sud America 7
Totale 12.080
Nazione #
US - Stati Uniti d'America 4.962
IE - Irlanda 1.967
CN - Cina 1.607
UA - Ucraina 1.280
SE - Svezia 723
IT - Italia 296
FI - Finlandia 232
FR - Francia 212
IN - India 202
TR - Turchia 157
DE - Germania 120
GB - Regno Unito 114
BE - Belgio 67
CA - Canada 20
KR - Corea 20
RU - Federazione Russa 16
EU - Europa 14
PK - Pakistan 11
NL - Olanda 10
ES - Italia 9
AU - Australia 7
CL - Cile 5
JP - Giappone 4
IQ - Iraq 3
SA - Arabia Saudita 3
BR - Brasile 2
CZ - Repubblica Ceca 2
IR - Iran 2
MY - Malesia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EE - Estonia 1
GR - Grecia 1
ID - Indonesia 1
KH - Cambogia 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 12.080
Città #
Dublin 1.967
Chandler 1.022
Jacksonville 910
Dearborn 532
Nyköping 484
Nanjing 461
Wilmington 214
Beijing 201
Nanchang 191
Princeton 188
San Mateo 181
Shenyang 120
Ann Arbor 96
Hebei 83
Ashburn 80
Boardman 77
Des Moines 76
Helsinki 67
Jiaxing 66
Kunming 65
Brussels 64
Changsha 64
Tianjin 60
Jinan 47
Woodbridge 40
Hangzhou 39
Ningbo 36
Zhengzhou 33
Foggia 31
Taizhou 28
Hilden 24
Lanzhou 20
Auburn Hills 18
Guangzhou 18
Augusta 15
Bari 15
Orange 15
Changchun 14
Norwalk 12
Rome 12
Shanghai 12
Falls Church 11
Lahore 11
Los Angeles 11
Toronto 11
Fuzhou 10
Leawood 10
Philadelphia 10
Saint Petersburg 9
Washington 9
Milan 7
San Francisco 7
Bologna 6
Haikou 6
Hefei 6
London 6
Paris 5
Redwood City 5
Bisceglie 4
Borås 4
Kolkata 4
Murcia 4
Palese 4
Rockville 4
Stevenage 4
Amsterdam 3
Avigliano 3
Baghdad 3
El Segundo 3
Florence 3
Frankfurt am Main 3
Genova 3
Kocaeli 3
Melbourne 3
Mountain View 3
Noicattaro 3
Redmond 3
Bangalore 2
Bitetto 2
Bitonto 2
Brescia 2
Canosa Di Puglia 2
Chengdu 2
Chicago 2
Crevalcore 2
Fiorano Modenese 2
Fremont 2
Gothenburg 2
Hanover 2
Jinhua 2
Lavagna 2
Münster 2
New York 2
Padova 2
Parma 2
San Severino Marche 2
Shaoxing 2
Taiyuan 2
Tappahannock 2
Trieste 2
Totale 7.948
Nome #
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 196
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 130
La riduzione dei livelli sierici di BAFF e APRIL si associa alla negativizzazione degli anticorpi anti-recettore della fosfolipasi A2 (PLA2R) nei pazienti affetti da glomerulonefrite membranosa idiopatica (iMN) 119
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 110
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 108
Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? 108
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 105
Sirolimus interferes with iron homeostasis in renal transplant recipients 104
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 102
Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy. 98
“Urinary epidermal growth factor (EGF) concentration in children affected by severe obstructive and reflux uropathy”. 97
PROSTATE CANCER IS CHARACTERIZED BY A DYSREGULATION OF THE IMMUNE RESPONSE 96
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 95
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 93
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 93
“Espressione renale della proteina chemotattica per i monociti (MCP-1) e del fattore di crescita epidermico (EGF) in bambini affetti da stenosi del giunto pielo-ureterale (SGPU).” 92
ADAMTS13 MUTATIONS AND POLYMORPHISMS IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA. 91
[Cardiovascular risk in polycystic kidney disease] 90
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 89
Renal cortical complement C3 gene expression in IgA nephropathy 89
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 89
Epidemal growth factor and monocyte chemotactic protein-1 renal expression and urinary levels in pediatric ureteropelvic junction obstruction 87
Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients 87
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 87
Creazione di un database multimediale per la gestione della telepatologia statica e della telemorfometria nella immunopatologia renale 86
“Epidermal growth factor (EGF) and monocyte chemotactic peptide-1 (MCP-1) renal expression in children affected by ureteropelvic junction obstruction” 86
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 86
La Fetuina A è ridotta nel siero e nelle urine dei pazienti affetti da nefro-urolitiasi ricorrente 86
Cardiovascular risk and renal transplantation 85
A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. 84
Espressione renale e livelli urinari di fattore di crescita epidermico ed proteina chemotattica dei monociti-1 in bambini con stenosi del giunto pielo-ureterale 83
Clinical and therapeutic aspects of diabetic nephropathy 83
Fibrin down-regulates LPS- and PMA- induced tissue factor expression by blood mononuclear cells. 82
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 82
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. 82
High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. 82
Thrombin: a novel renal growth factor. 81
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 80
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 80
Acute renal failure in critically ill patients. 79
Placental imbalance of vasoactive factors does not affect pregnancy outcome in patients treated with cyclosporine A after transplant 79
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 78
Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction 77
INCREASE OF PROLIFERATING RENAL PROGENITOR CELLS IN ACUTE TUBULAR NECROSIS UNDERLYING DELAYED GRAFT FUNCTION IN KIDNEY TRANSPLANTATION 77
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. 77
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 76
Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients. 76
Proteomic profile of plasma proteins eluted from Coupled Plasma Filtration-Adsorption (CPFA) sorbent resin cartridges in a swine model of sepsis 76
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 75
Children with obstructive uropathy showed renal overexpression of plasminogen activator inhibitor-1 unrelated to renal expression of angiotensinogen 74
Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase. 74
Altered urinary excretion of aquaporin 2 in IgA nephropathy. 73
Rapamycin treatment for benign multicystic peritoneal mesothelioma: A rare disease with a difficult management 73
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 72
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 72
Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. 72
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 72
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation 72
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 72
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 72
Clinical relevance of citokine production in hemodialysis. 71
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 70
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 70
Angiotensin Inhibition Mycophenolate mophetil IgA Nephropathy study investigators. One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study. 70
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 70
Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy. 70
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 70
Cytokines and bioincompatibility 69
Trapianto di rene doppio. Analisi retrospettiva dei dati relativi alla popolazione dei pazienti portatori di trapianto renale doppio in ambito AIRT 69
Acute kidney injury in the elderly population. 69
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 69
“Monocyte chemotatic protein-1 and epidermal growth factor (EGF) expression and secretion in xanthogranulomatous pyelonephritis 68
Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. 68
In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD. 67
A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant. 67
Actions of platelet-derived growth factor isoforms in mesangial cells. 67
mTOR inhibitors effects on regulatory T cells and on dendritic cells 67
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics 67
Angiotensin IV and renal diseases. 66
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 66
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) 66
Management of Side Effects of Sirolimus Therapy. 65
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression 65
Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction. 65
Vitamin E-modified filters modulate Jun N-terminal kinase activation in peripheral blood mononuclear cells. 65
Management and prevention of post-transplant malignancies in kidney transplant recipients 65
Treatment with rituximab in idiopathic membranous nephropathy 65
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 64
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 64
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN DULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION. 64
Inflammation and carnitine in hemodialysis patients. 64
Renal injury after low-or iso-osmolar contrast agent exposure:an in vitro study 64
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 64
Early withdrawal of cyclosporine improves 1-year kidney graft structure and function in Sirolimus-treated patients: Response to the authours 63
The role of tubular cells in the progression of renal damage: guilty or innocent? 63
Allograft nephrectomy: what is the best surgical technique? 63
Rapamycin induces ILT3highILT4high dendritic cells promoting a new immunoregulatory pathway 63
The role of hyperparathyroidism, erythropoietin therapy, and CMV infections in the failure of arteriovenous fistula in hemodialysis. 62
Recidive della nefropatia di base e nefropatie “de novo” in pazienti portatori di trapianto renale 62
“Renal expression of monocyte chemotatic protein-1 (MCP-1) and epidermal growth factor (EGF) in children with obstructive hydronephrosis 61
Totale 7.918
Categoria #
all - tutte 43.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.479


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019897 0 0 0 0 0 223 298 28 6 35 80 227
2019/20202.863 633 384 136 35 333 312 452 35 244 42 234 23
2020/20211.460 197 8 190 10 187 100 214 61 209 269 12 3
2021/2022963 171 3 39 15 63 16 17 76 123 112 35 293
2022/20234.444 375 200 243 247 221 353 41 307 2.252 20 73 112
2023/2024315 94 25 38 38 60 60 0 0 0 0 0 0
Totale 12.326